Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

S. Darb-Esfahani*, R. Kronenwett, G. Von Minckwitz, C. Denkert, M. Gehrmann, A. Rody, J. Budczies, J. C. Brase, M. K. Mehta, H. Bojar, B. Ataseven, T. Karn, E. Weiss, D. M. Zahm, F. Khandan, M. Dietel, S. Loibl

*Corresponding author for this work
22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology